Clinical Trial Update: Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab for relapsed, locally recurrent squamous cell carcinoma of the head and neck; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Assuntina G. Sacco, MD | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: ACTIVE_NOT_RECRUITING